Home Conferences & TrainingAnnual Conference Continuing Education

Continuing Education

The CHADD conference provides continuing education for Physicians, Nurses, Mental Health Professionals (Psychologists, Social Workers, Therapists), and Educators. Continuing Education credits (CEs) for mental health professionals are being offered through PsychoEducational Resources, Inc. (PER).

Continuing education Continuing education Educator seminar

CONTINUING EDUCATION

CONTINUING EDUCATION FOR COACHES

Coaches attending session WB3, TA6, TB2, FD12 will receive completion certificate for hours of training, which can be used toward international Coaching Federation (ICF) credentialing. A certificate of attendance will be provided for all other sessions.

CONTINUING EDUCATION FOR EDUCATORS

As an IACET Authorized Provider, CHADD offers CEUs for its programs that qualify under IACET guidelines.
• CHADD is authorized by IACET to offer 3.05 CEUs for this program, (equivalent to 30.5 hours of attendance).

Mental Health Professionals:

Continuing Education credits (CEs) for mental health professionals are being offered through PsychoEducational Resources, Inc. (PER).

Participants may earn three (3) CEs for WA2 - Complimentary Session   or Pre-Conference Institute on Wednesday, up to six (6) CEs for Pre-Conference Institutes on Thursday (3 per session), and up to nine (9) CEs for General Conference Sessions on Friday & Saturday (1.5 per session).

Sessions Approved for Mental Health CEs:

Wednesday, October 7, 2009

     WA2  WB1  WB2   WB4     WB5 

Thursday, October 8, 2009

    TA1 TA2  TA3  TA4  TA5  TA6  TA7   TB1  TB3  TB5  TB6

FRIDAY, OCTOBER 9, 2009

   RESEARCH SYMPOSIUM I    FB2     FB4   FC1  FC2  FC6    FC7    FC8    FC9   FC10    FC12   FD1   FD4   FD6   FD7   FD8     FD11  FD13

SATURDAY, OCTOBER 10, 2009

   RESEARCH SYMPOSIUM II   SB4    SC1  SC3    SC4   SC5     SC9     SC12    SD2     SD6     SD8     SD10     SD13

PER Sponsorships:

PER is approved by the American Psychological Association to sponsor continuing education for psychologists.   PER maintains responsibility for this program and its content.

PER is an NBCC Approved Continuing Education Provider (ACEP) and a co-sponsor of this program. PER may award NBCC approved clock hours for programs that meet NBCC requirements (Approval # 5536). Please check with your state counseling board to see if they accept the NBCC providership.

PER is approved as a provider for continuing education by the Association of Social Work Boards, 400 South Ridge Parkway, Suite B, Culpepper, VA 22701. www.aswb.org. ASWB Approval Period: 4/15/09 – 4/15/12. Social workers should contact their regulatory board to determine course approval. The following recognize the ASWB program: AL, AK, AZ, CT, DC, DE, GA, ID, IN, IA, KY, MA, MD, MI, MO, MS, MT, NM, NC, ND, NJ, OK, OR, PA, RI, SC, TN, TX, UT, VA, VI, VT, WA, WI, and WY.

PER is also an approved provider with a variety of individual state social work boards which include: the Alabama Social Work Board (#0155), the Florida Board of Licensed Clinical Social Work, Marriage and Family Therapy, and Mental Health Counseling (CE Provider Tracking #50-1657, Board Provider #351, exp. 03/31/11), the Illinois Social Work Board (159-000505), the Iowa Board of Social Work (#153), the Maryland State Board of Social Work, the Ohio Social Work Board (RSX-019601), and the Texas Board of Social Work (CS 1596).

Course meets the qualifications for continuing education credit for MFTs and/or LCSWs as required by the California Board of Behavioral Sciences (Provider #PCE 203).

PER is an approved provider with the Illinois Marriage and Family Therapist Board (#168-000125)

PER is an approved Counselor (RCX-129413) provider with the Ohio Counselor, Social Worker and Marriage and Family Therapist Board.

PER is a provider of continuing education with the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists (#98). Please note that the Board will only accept CE hours for renewal purposes that are related to the professional license that is being renewed and hours that are related to the educational requirements or subject matter that is required for the licensure.

PER is an approved provider with the Texas State Board of Examiners of MFTs (#130).

PER is approved as a Continuing Education Provider by the National Association of Alcoholism and Drug Abuse Counselors (NAADAC) Provider #374. The individual sessions in this conference cover the following counselor skill groups: clinical assessment, ongoing treatment planning, and counseling services.  

PER maintains responsibility for this program and its content.

For additional CE information please call PER at 800-892-9249 or e-mail support@per-ce.net.

To receive CE Certification you must complete the conference evaluation, an evaluation for each session you attend, the CE Request Form, and sign in and out of each session attended. CE Certification will be mailed to you approximately 6-8 weeks from the conclusion of the conference.

CME Information and Sessions Approved

Physician and Nursing Continuing Education

This activity is jointly sponsored by Clobal Education group and Children and Adults with Attention deficit/Hyperactivity Disorder (CHADD)

Target Audience

The educational design of this activity addresses the needs of pediatricians, child psychiatrists, neurologists, family practitioners and nurses involved in the treatment of patients with AD/HD.

Statement of Need/Program Overview

Statement of Needs for AD/HD in Adults
Attention-Deficit/Hyperactivity Disorder (AD/HD) affects about 4.4% of adults between the ages of 18 and 33 in the United States and studies suggest that adults with AD/HD experience considerable impairment in quality of life and in academic, occupational, and social functioning. Furthermore, they experience high rates of comorbidities that exacerbate their distress and make it difficult  to function on a daily basis. With increased recognition that AD/HD may be a lifelong disorder and can significantly affect adults  the American Psychiatric Association has placed a greater emphasis on training physicians on recognizing and treating AD/HD. Access to diagnosis and treatment is limited for adults affected by AD/HD. Although many medication treatments are available to manage AD/HD, much remains to clarify their efficacy and safety in adults.

Statement of Needs for  AD/HD in Children Nearly 8 percent of all school age children age 4 to 17 years have been diagnosed with AD/HD sometime in their lives, according to the U.S. Centers for Disease Control and Prevention (CDC). Children with AD/HD receive much of their care from primary care clinicians who make the initial diagnosis, manage the child's care, and supervise treatment. Children with AD/HD use significantly more health care services than do children who do not have AD/HD. They have more primary care visits, more mental health visits, and more pharmaceutical use compared with other children. With over 4 million children in the United States identified as having AD/HD and with their need for medical services far exceeding children who do not have AD/HD these children place a great demand on primary care clinicians to provide what is often complicated treatment that requires long-term management.

Educational Objectives

After completing this activity, the participant should be better able to:
Describe the implications for clinical practice for combined behavioral intervention and pharmacotherapy
Explain how findings from basic research can be translated to the clinical setting, and inform our understanding of AD/HD and its treatment.
Review data that can be used to develop treatment plans for individuals with autism and AD/HD.
Identify the latest advances in research and practice
Recognize the current conceptualization of AD/HD as a neurobehavioral disorder
Identify the most effective medication treatments.
Identify the most effective psychotherapeutic treatments.
Describe an ideal treatment “package” or combination of treatments

Faculty

Dr. Eric Stull, M.D.
Developmental/Behavioral Pediatrician
Partners in Attention

Dr. Steven Kennelly, Ph.D.
Pediatric Neuropsychologist
Princeton Center for Therapy & Assessment

Dr. Jefferson Prince, M.D.
Instructor in Psychology
Harvard Medical School, and Child and Adolescent Psychiatrist, North Shore Medical Center

Dr. J. Russell Ramsay, Ph.D.
Assistant Professor of Psychology
Adult ADHD Treatment and Research Program/University Of Pennsylvania

Dr. James Swanson, Ph.D.
Developmental Psychologist, specializing in Research and Treatment of children with AD/HD
UCI Child Development Center

Dr. L. Eugene Arnold, M.D.
Professor Emeritus of Psychiatry
Ohio State University

Dr. Lidia Zylowska, M.D.
Associate Clinical Professor and Adult Psychologist/Private Practice UCLA Mindful Awareness Research Center

Dr. Mark Bertin, M.D.
Assistant Professor of Pediatrics New York Medical College Director of Developmental Behavioral Pediatrics at the Westchester Institute for Human Development

Program Agenda

FRIDAY, OCTOBER 9, 4:00 p.m. - 5:30 p.m.

FD1 Medication Treatments for AD/HD Across the Lifespan
Intermediate/Lecture/M.D., Psychologist, Healthcare, Parent, Caregiver, Adult
Jefferson Prince, M.D., Harvard Medical School

FD8 Neuropsychological Evaluation on AD/HD: how Testing Can Support Diagnosis and Treatment
Intermediate/Seminar/Psychologist, Healthcare, M.D., Parents, Educators
Steven Kennelly, Ph.D., Princeton Center for Therapy & Assessment

FD11 Beyond Medication: Adjunctive Treatments for Adults with AD/HD
Beginning/Seminar/Adult, Psychologist, Healthcare, M.D.
J. Russell Ramsey, Ph.D., University Of Pennsylvania

FD13 Optimizing Medication in AD/HD: The Secrets to Success
Intermediate/Lecture/M.D., Healthcare, Psychologist
Eric Stull, M.D., Partners in Attention

SATURDAY, OCTOBER 10,  10:30 a.m. - 12:00 p.m.

SBRII - Research Symposium II
Seminar/Intermediate-Advanced/All
James Swanson, Ph.D., UCI Child Development Center, Facilitator
L. Eugene Arnold, M.D., Ohio State University

SATURDAY,  OCTOBER 10, 3:30 p.m. - 5:00 p.m.

SD13 Principles of Mindfulness-Based Training
Beginning/Workshop/Healathcare, M.D., Psychologist
Lidia Zylowska, M.D., UCLA Mindful Awareness Research Center; Mark Bertin, M.D., New York Medical College
 
ALL OTHER SESSIONS ARE NOT CME ACCREDITED!

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and Children & Adults with Attention-Deficit/Hyperactivity Disorder (CHADD). Global is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Global Education Group designates this educational activity for a maximum of 4.0 AMA PRA Category 1 Credit(s)™.  Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician and Nursing Continuing Education

CNA/ANCC

This educational activity for 4 contact hours is provided by Global Education Group.

Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Register Online Now!

To download a registration form click here<font face="Times &#13;&#13;&#10;&amp;#13;&amp;#13;amp;